Clinical Trial Update: Dihydroartemisinin-piperaquine With Low Dose Primaquine to Reduce Malaria Transmission [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dihydroartemisinin-piperaquine with low-dose primaquine to reduce malaria transmission has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asymptomatic Malaria
• Malaria
• Plasmodium Falciparum Malaria

Drugs mentioned

• Dihydroartemisinin-piperaquine (dihydroartemisinin-piperaquine)
• Primaquine (primaquine)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria, Asymptomatic Malaria | Phase 3 | Status: COMPLETED